CAC
ADGM

Cowen and Company’s Adagio Medical Holdings ADGM Stock Holding History

Cowen and Company’s Portfolio ADGM Stock Details ADGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,000
Closed -$69.7K – 376
2024
Q3 		$69.7K Buy
+27,000
New +$129K ﹤0.01% 316

Other funds holding ADGM

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Cowen and Company's ADGM Position: Q4 2024 in Review

Cowen and Company sold out of Adagio Medical Holdings (ADGM) in Q4 2024, closing a stake of 27,000 shares — an estimated $69.7K sold.

Cowen and Company first reported a position in ADGM in Q3 2024 and held it in 1 quarter. The position peaked at $69.7K in Q3 2024. 15 funds tracked by Wall St. Rank hold ADGM as of Q4 2024.

  • Cowen and Company reported no remaining Adagio Medical Holdings position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 27,000 Adagio Medical Holdings shares in Q4 2024, an estimated $69.7K.
  • Cowen and Company first reported a position in Adagio Medical Holdings in Q3 2024 and held it in 1 quarter.
  • Cowen and Company's Adagio Medical Holdings position peaked at $69.7K in Q3 2024.
  • 15 funds tracked by Wall St. Rank held Adagio Medical Holdings as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.